The vaccinations would observe the SOPs as beneficial by the federal government together with registration on CoWIN.
“This pilot phase will allow Dr. Reddy’s and Apollo to test the arrangements and cold chain logistics and prepare for the launch. We are confident that with the Sputnik V vaccine, we will be able to make a significant contribution to ease availability and access to COVID vaccines to the community at large,” Apollo Hospitals President – Hospitals Division Okay Hari Prasad mentioned in an announcement.
With the opening up of the vaccination programme for the non-public sector, the healthcare main has intensified efforts to speed up the speed of vaccination by opening vaccination centres throughout its hospital community, he added.
“We are also in discussions with corporates to undertake vaccination on their premises. We are currently administering COVID vaccine at 60 locations across the country including Apollo Hospitals, Apollo Spectra hospitals and Apollo Clinics,” Prasad mentioned.
Dr Reddy’s Laboratories CEO – Branded Markets (India & Emerging Markets) MV Ramana famous that the 2 entities have been working to scale up the pilot and take the vaccine to different cities with an intention to inoculate as many Indians as potential.
The Sputnik V vaccines for the pilot programme could be equipped by Dr Reddy’s from the primary batch of 1.5 lakh doses imported to date.
After Hyderabad and Visakhapatnam, the pilot programme will probably be prolonged to Delhi, Mumbai, Bengaluru, Ahmedabad, Chennai, Kolkata, and Pune.
In August 2020, Russia turned the world’s first nation to register a coronavirus vaccine, dubbed as Sputnik V.
Following that, in September, Dr Reddy’s Laboratories and Russian Direct Investment Fund (RDIF) entered right into a partnership to conduct medical trials of Sputnik V, which is developed by the Gamaleya National Research Institute of Epidemiology and Microbiology.
Dr Reddy’s Laboratories has acquired approval from the Indian drug regulator for restricted emergency use of Sputnik V.